Coeptis Therapeutics Hldgs Inc (COEP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 3,685 | 6,539 | 3,099 | 5,569 | 9,813 |
| Operating Income | -3,685 | -6,539 | -3,099 | -5,569 | -9,813 |
| Interest Expense | 43 | 31 | 163 | 56 | 64 |
| Other Income | 525 | -1,387 | 319 | -24 | 74 |
| Pre-tax Income | -3,203 | -7,958 | -2,943 | -5,649 | -9,803 |
| Net Income Continuous | -3,203 | -7,958 | -2,943 | -5,649 | -9,803 |
| Net Income | $-3,203 | $-7,958 | $-2,943 | $-5,649 | $-9,803 |
| EPS Basic Total Ops | -3.00 | -8.00 | 1.20 | -8.40 | -15.00 |
| EPS Basic Continuous Ops | -2.94 | -7.92 | 1.32 | -8.40 | -15.06 |
| EPS Diluted Total Ops | -3.00 | -8.00 | 1.20 | -8.40 | -15.00 |
| EPS Diluted Continuous Ops | -2.94 | -7.92 | 1.32 | -8.40 | -15.06 |
| EBITDA(a) | $-3,435 | $-6,289 | $-2,849 | $-5,262 | $-9,499 |